Rockwell Medical Statistics
Share Statistics
Rockwell Medical has 32.32M shares outstanding. The number of shares has increased by 10.17% in one year.
| Shares Outstanding | 32.32M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 4.15% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 28.04M |
| Failed to Deliver (FTD) Shares | 6.05K |
| FTD / Avg. Volume | 0.83% |
Short Selling Information
The latest short interest is 823.37K, so 2.55% of the outstanding shares have been sold short.
| Short Interest | 823.37K |
| Short % of Shares Out | 2.55% |
| Short % of Float | 2.94% |
| Short Ratio (days to cover) | 1.51 |
Valuation Ratios
The PE ratio is -5.22 and the forward PE ratio is 42.71.
| PE Ratio | -5.22 |
| Forward PE | 42.71 |
| PS Ratio | 0.53 |
| Forward PS | 0.8 |
| PB Ratio | 2.07 |
| P/FCF Ratio | -4.55 |
| PEG Ratio | n/a |
Enterprise Valuation
Rockwell Medical Inc. has an Enterprise Value (EV) of 48.54M.
| EV / Earnings | -5.75 |
| EV / Sales | 0.58 |
| EV / EBITDA | -10.34 |
| EV / EBIT | -7.28 |
| EV / FCF | -5.01 |
Financial Position
The company has a current ratio of 1.73, with a Debt / Equity ratio of 0.4.
| Current Ratio | 1.73 |
| Quick Ratio | 1.38 |
| Debt / Equity | 0.4 |
| Total Debt / Capitalization | 28.62 |
| Cash Flow / Debt | -1.1 |
| Interest Coverage | -2.9 |
Financial Efficiency
Return on equity (ROE) is -0.4% and return on capital (ROIC) is -19.21%.
| Return on Equity (ROE) | -0.4% |
| Return on Assets (ROA) | -0.16% |
| Return on Capital (ROIC) | -19.21% |
| Revenue Per Employee | 352.79K |
| Profits Per Employee | -35.61K |
| Employee Count | 237 |
| Asset Turnover | 1.6 |
| Inventory Turnover | 12.76 |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by 35.14% in the last 52 weeks. The beta is 1.5, so Rockwell Medical 's price volatility has been higher than the market average.
| Beta | 1.5 |
| 52-Week Price Change | 35.14% |
| 50-Day Moving Average | 2.51 |
| 200-Day Moving Average | 2.42 |
| Relative Strength Index (RSI) | 38.29 |
| Average Volume (20 Days) | 726.41K |
Income Statement
In the last 12 months, Rockwell Medical had revenue of 83.61M and earned -8.44M in profits. Earnings per share was -0.36.
| Revenue | 83.61M |
| Gross Profit | 8.70M |
| Operating Income | -6.67M |
| Net Income | -8.44M |
| EBITDA | -4.69M |
| EBIT | -6.67M |
| Earnings Per Share (EPS) | -0.36 |
Balance Sheet
The company has 8.98M in cash and 13.44M in debt, giving a net cash position of -4.46M.
| Cash & Cash Equivalents | 8.98M |
| Total Debt | 13.44M |
| Net Cash | -4.46M |
| Retained Earnings | -397.20M |
| Total Assets | 57.08M |
| Working Capital | 20.04M |
Cash Flow
In the last 12 months, operating cash flow was -9.41M and capital expenditures -284.00K, giving a free cash flow of -9.70M.
| Operating Cash Flow | -9.41M |
| Capital Expenditures | -284.00K |
| Free Cash Flow | -9.70M |
| FCF Per Share | -0.42 |
Margins
Gross margin is 10.41%, with operating and profit margins of -7.98% and -10.09%.
| Gross Margin | 10.41% |
| Operating Margin | -7.98% |
| Pretax Margin | -10.09% |
| Profit Margin | -10.09% |
| EBITDA Margin | -5.61% |
| EBIT Margin | -7.98% |
| FCF Margin | -11.6% |
Dividends & Yields
RMTI does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -18% |
| FCF Yield | -15.04% |
Analyst Forecast
The average price target for RMTI is $6, which is 200% higher than the current price. The consensus rating is "Buy".
| Price Target | $6 |
| Price Target Difference | 200% |
| Analyst Consensus | Buy |
| Analyst Count | 2 |
Stock Splits
The last stock split was on May 13, 2022. It was a backward split with a ratio of 1:11.
| Last Split Date | May 13, 2022 |
| Split Type | backward |
| Split Ratio | 1:11 |
Scores
| Altman Z-Score | -5.97 |
| Piotroski F-Score | 5 |